Molecular Interaction Between Vasopressin and Insulin in Regulation of Metabolism: Impact on Cardiovascular and Metabolic Diseases

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2025 Jan 8

PMID 39769071

Authors

Ewa Szczepanska-Sadowska

Agnieszka Cudnoch-Jedrzejewska

Tymoteusz Zera

Affiliations

Soon will be listed here.

Abstract

Numerous compounds involved in the regulation of the cardiovascular system are also engaged in the control of metabolism. This review gives a survey of literature showing that arginine vasopressin (AVP), which is an effective cardiovascular peptide, exerts several direct and indirect metabolic effects and may play the role of the link adjusting blood supply to metabolism of tissues. Secretion of AVP and activation of AVP receptors are regulated by changes in blood pressure and body fluid osmolality, hypoxia, hyperglycemia, oxidative stress, inflammation, and several metabolic hormones; moreover, AVP turnover is regulated by insulin. Acting on V1a receptors in the liver, AVP stimulates glycogenolysis, reduces synthesis of glycogen, and promotes fatty acid synthesis and acetyl CoA carboxylase activity. Stimulating V1b receptors in the pancreatic islands, AVP promotes release of insulin and glucagon-like peptide-1 (GLP-1) and potentiates stimulatory effects of glucose and ACTH on secretion of insulin. Simultaneously, insulin increases AVP secretion by neurons of the paraventricular nucleus and the supraoptic nucleus. There is strong evidence that secretion of AVP and its metabolic effectiveness are significantly altered in metabolic and cardiovascular diseases. Both experimental and clinical data indicate that inappropriate interactions of AVP and insulin play an important role in the development of insulin resistance in obesity and diabetes mellitus.

References

Kiyomoto K, Tamaki T, Tomohiro A, Nishiyama A, Aki Y, Kimura S . Role of nitric oxide in desmopressin-induced vasodilation of microperfused rabbit afferent arterioles. Hypertens Res. 1997; 20(1):29-34. DOI: 10.1291/hypres.20.29. View

Stern J, Ludwig M . NO inhibits supraoptic oxytocin and vasopressin neurons via activation of GABAergic synaptic inputs. Am J Physiol Regul Integr Comp Physiol. 2001; 280(6):R1815-22. DOI: 10.1152/ajpregu.2001.280.6.R1815. View

Szczepanska-Sadowska E, Zera T, Sosnowski P, Cudnoch-Jedrzejewska A, Puszko A, Misicka A . Vasopressin and Related Peptides; Potential Value in Diagnosis, Prognosis and Treatment of Clinical Disorders. Curr Drug Metab. 2017; 18(4):306-345. DOI: 10.2174/1389200218666170119145900. View

Swords B, Wyss J, Berecek K . Central vasopressin receptors are upregulated by deoxycorticosterone acetate. Brain Res. 1991; 559(1):10-6. DOI: 10.1016/0006-8993(91)90280-9. View

Yamamoto K, Ikeda U, Okada K, Saito T, Kawahara Y, Okuda M . Arginine vasopressin increases nitric oxide synthesis in cytokine-stimulated rat cardiac myocytes. Hypertension. 1997; 30(5):1112-20. DOI: 10.1161/01.hyp.30.5.1112. View

Plotsky P, Bruhn T, Vale W . Hypophysiotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycemia. Endocrinology. 1985; 117(1):323-9. DOI: 10.1210/endo-117-1-323. View

Tobin V, Hashimoto H, Wacker D, Takayanagi Y, Langnaese K, Caquineau C . An intrinsic vasopressin system in the olfactory bulb is involved in social recognition. Nature. 2010; 464(7287):413-7. PMC: 2842245. DOI: 10.1038/nature08826. View

Lolait S, OCarroll A, Mahan L, Felder C, Button D, Young 3rd W . Extrapituitary expression of the rat V1b vasopressin receptor gene. Proc Natl Acad Sci U S A. 1995; 92(15):6783-7. PMC: 41413. DOI: 10.1073/pnas.92.15.6783. View

El Boustany R . Vasopressin and Diabetic Kidney Disease. Ann Nutr Metab. 2018; 72 Suppl 2:17-20. DOI: 10.1159/000488124. View

10.

Schmale H, Heinsohn S, Richter D . Structural organization of the rat gene for the arginine vasopressin-neurophysin precursor. EMBO J. 1983; 2(5):763-7. PMC: 555182. DOI: 10.1002/j.1460-2075.1983.tb01497.x. View

11.

Then C, Kowall B, Lechner A, Meisinger C, Heier M, Koenig W . Plasma copeptin is associated with type 2 diabetes in men but not in women in the population-based KORA F4 study. Acta Diabetol. 2014; 52(1):103-12. DOI: 10.1007/s00592-014-0609-8. View

12.

Fernandez A, Hernandez-Garzon E, Perez-Domper P, Perez-Alvarez A, Mederos S, Matsui T . Insulin Regulates Astrocytic Glucose Handling Through Cooperation With IGF-I. Diabetes. 2016; 66(1):64-74. DOI: 10.2337/db16-0861. View

13.

Morita M, Kita Y, Morikawa N, Iwami M, Notsu Y . Expression of arginine vasopressin and vasopressin V1a receptor mRNA in diabetic (db/db) mice. Exp Clin Endocrinol Diabetes. 2001; 109(5):261-6. DOI: 10.1055/s-2001-16345. View

14.

Wan E, Fung C, Jiao F, Yu E, Chin W, Fong D . Five-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on Diabetes-Related Complications and Health Service Uses-A Population-Based and Propensity-Matched Cohort Study. Diabetes Care. 2017; 41(1):49-59. DOI: 10.2337/dc17-0426. View

15.

Tahara A, Tsukada J, Tomura Y, Yatsu T, Shibasaki M . Downregulation of vasopressin V1A receptors and activation of mitogen-activated protein kinase in rat mesangial cells cultured under high-glucose conditions. Clin Exp Pharmacol Physiol. 2012; 39(5):438-46. DOI: 10.1111/j.1440-1681.2012.05693.x. View

16.

Kalsbeek A, La Fleur S, van Heijningen C, Buijs R . Suprachiasmatic GABAergic inputs to the paraventricular nucleus control plasma glucose concentrations in the rat via sympathetic innervation of the liver. J Neurosci. 2004; 24(35):7604-13. PMC: 6729629. DOI: 10.1523/JNEUROSCI.5328-03.2004. View

17.

Sanada K, Yoshimura M, Ikeda N, Baba K, Nishimura H, Nishimura K . Chemogenetic activation of endogenous arginine vasopressin exerts anorexigenic effects via central nesfatin-1/NucB2 pathway. J Physiol Sci. 2021; 71(1):18. PMC: 10717637. DOI: 10.1186/s12576-021-00802-4. View

18.

Hill J, Lesniak M, Pert C, Roth J . Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas. Neuroscience. 1986; 17(4):1127-38. DOI: 10.1016/0306-4522(86)90082-5. View

19.

Szczepanska-Sadowska E, Wsol A, Cudnoch-Jedrzejewska A, Zera T . Complementary Role of Oxytocin and Vasopressin in Cardiovascular Regulation. Int J Mol Sci. 2021; 22(21). PMC: 8584236. DOI: 10.3390/ijms222111465. View

20.

Karbach S, Jansen T, Horke S, Heeren T, Scholz A, Coldewey M . Hyperglycemia and oxidative stress in cultured endothelial cells--a comparison of primary endothelial cells with an immortalized endothelial cell line. J Diabetes Complications. 2012; 26(3):155-62. DOI: 10.1016/j.jdiacomp.2012.03.011. View